Thought Leadership

Latest Report

Thumbnail

Vantage 2019 Preview

2019 expected to be volatile year for pharma and biotech industries The Vantage 2019 Preview looks at the risks and opportunities for the year ahead. Report Highlights Venture capital and IPO markets are expected to retrench The US FDA is expected to remain business friendly, but political gridlock may hinder pricing legislation Alexion’s…

Report library

Thumbnail

EvaluatePharma Orphan Drug Report 2018

Report Highlights Worldwide orphan drug sales are forecasted to grow at a CAGR of 11% from 2018-2024 The mean price of the top 100 USA orphan drugs is expected to…

Thumbnail

EP Vantage 2018 Preview

Report Highlights M&A activity expected to climb after slow 2017 – US tax reform a deciding factor for big deals Another big year predicted for venture financing…